뇌 산소포화도 모니터링 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Cerebral Oximetry Monitoring Market size is expected to reach USD 516.55 Million in 2034 from USD 266.51 Million (2025) growing at a CAGR of 7.63% during 2026-2034.

The Global Cerebral Oximetry Monitoring Market is growing steadily due to rising awareness of brain health monitoring during surgeries and critical care procedures. These devices measure oxygen saturation in the brain, helping prevent neurological complications. Increasing prevalence of cardiovascular and neurological disorders has boosted demand for advanced monitoring systems. Expanding healthcare infrastructure and technological advancements in non-invasive monitoring solutions are supporting global market growth.

Key drivers include the growing number of surgical procedures, particularly cardiac and neonatal surgeries. Hospitals are increasingly adopting cerebral oximetry systems to enhance patient safety and improve surgical outcomes. Technological innovation, including portable and wireless monitoring devices, is making these systems more accessible. Additionally, aging populations worldwide are increasing the incidence of chronic conditions requiring advanced perioperative monitoring.

In the future, integration with digital health platforms and real-time data analytics will enhance clinical decision-making. Expanding healthcare access in emerging economies will create new growth opportunities. Continuous improvements in sensor accuracy and miniaturization will further drive adoption. As patient safety standards become more stringent, cerebral oximetry monitoring is expected to remain a critical component of advanced medical care systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Cardiac Surgery
• Vascular Surgery
• Others

By Age Group

• Pediatric
• Adult

By End Use

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Masimo Corporation, Medtronic plc, Edwards Lifesciences Corporation, Nonin Medical Inc, ISS Inc, Hamamatsu Photonics KK, Mespere LifeSciences Inc, GE HealthCare, Terumo Cardiovascular Systems Corporation, Philips Healthcare
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CEREBRAL OXIMETRY MONITORING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Cardiac Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Vascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CEREBRAL OXIMETRY MONITORING MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Age Group
• 5.2. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CEREBRAL OXIMETRY MONITORING MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CEREBRAL OXIMETRY MONITORING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Age Group
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Age Group
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Age Group
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Age Group
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Age Group
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CEREBRAL OXIMETRY MONITORING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Masimo Corporation
  • 9.2.2 Medtronic Plc
  • 9.2.3 Edwards Lifesciences Corporation
  • 9.2.4 Nonin Medical Inc
  • 9.2.5 ISS Inc
  • 9.2.6 Hamamatsu Photonics K.K
  • 9.2.7 Mespere LifeSciences Inc
  • 9.2.8 GE HealthCare
  • 9.2.9 Terumo Cardiovascular Systems Corporation
  • 9.2.10 Philips Healthcare